Market Capitalization

Pfizer projects lower 2026 earnings as COVID sales wane and patents expire, shifting focus to a multi-billion dollar R&D push for future growth.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

A decade after his passing, a hyper-exclusive David Bowie tribute redefines luxury, blending musical authenticity with bespoke hospitality for a new class of investor.

Talen Energy unveils a major executive overhaul and a novel compensation plan, signaling a strategic pivot to dominate the energy-hungry AI data center market.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.

Palantir's DGSI contract renewal isn't just a deal; it's a story of strategic reliance, political tension, and the bedrock of its business model.

This REIT's stock is worth millions, but it claims its apartments are worth much more. Can a bold strategic review unlock this hidden value for investors?

A junior miner is fast-tracking gold and critical metals production in Québec by reviving a key mill. Is this a strategic supply chain win or just savvy promotion?

Beyond the dividend payout, Cherry Hill Mortgage's strategy reveals a deeper pivot towards digital innovation, balancing high yields with new frontiers of risk.

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.

With a €1.5B capital raise backed by governments and strategic giants, Eutelsat is fueling its unique hybrid satellite network to compete in the new space race.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

A new partnership combines 3D depth with panoramic visuals, creating an unparalleled movie experience. But is it enough to win the premium cinema war?

Zoetis boosts its dividend by 6%, but what does this move signal about the company's financial health and the booming global animal care market?

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.

Argan's repeated dividend hikes and record backlog reflect deep confidence, positioning it to capitalize on surging demand for critical energy infrastructure.

Netflix is betting big on physical entertainment with its 'Netflix House,' a strategic pivot aiming to diversify revenue and redefine fan loyalty.

A $2.4B deal for Alphawave IP and a revealing investor filing pull back the curtain on the high-stakes race to build the infrastructure for an AI world.

Hong Kong's JM Group raised $15M in a wild NYSE debut. We look past the volatility to see what this IPO reveals about global supply chains and risk.